Anti-ITGAV+ITGB3 (Etaracizumab)-MC-MMAF ADC
This ADC product is comprised of an anti-ITGAV+ITGB3 monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
337821-01 50 µg
Transcription intermediary factor 1-beta (Tripartite Motif-Containing 28, Transcription Intermediary Factor 1-beta, RNF96, KAP1, TIF1B, Kap1, Tif1b, KRAB Associated Protein 1, KRAB Interacting Protein 1, KRAB-Associated Protein 1, KRAB-Interacting Protein 1, KRIP 1, KRIP1, KRIP-1, Krip1, Nuclear Corepressor KAP 1, Nuclear Corepressor KAP-1, RNF96, TIF1-beta)
Sign In for Pricing
View Details 337821-02 100 µg
Transcription intermediary factor 1-beta (Tripartite Motif-Containing 28, Transcription Intermediary Factor 1-beta, RNF96, KAP1, TIF1B, Kap1, Tif1b, KRAB Associated Protein 1, KRAB Interacting Protein 1, KRAB-Associated Protein 1, KRAB-Interacting Protein 1, KRIP 1, KRIP1, KRIP-1, Krip1, Nuclear Corepressor KAP 1, Nuclear Corepressor KAP-1, RNF96, TIF1-beta)
Sign In for Pricing
View Details